Protagonist Therapeutics (PTGX) Receivables - Other (2017 - 2025)
Historic Receivables - Other for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to $4.6 million.
- Protagonist Therapeutics' Receivables - Other changed N/A to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year change of. This contributed to the annual value of $165.0 million for FY2024, which is 6435312.5% up from last year.
- Per Protagonist Therapeutics' latest filing, its Receivables - Other stood at $4.6 million for Q3 2025.
- Protagonist Therapeutics' Receivables - Other's 5-year high stood at $165.0 million during Q4 2024, with a 5-year trough of $39000.0 in Q2 2023.
- For the 5-year period, Protagonist Therapeutics' Receivables - Other averaged around $17.1 million, with its median value being $2.6 million (2021).
- As far as peak fluctuations go, Protagonist Therapeutics' Receivables - Other plummeted by 9979.72% in 2023, and later skyrocketed by 6435312.5% in 2024.
- Over the past 5 years, Protagonist Therapeutics' Receivables - Other (Quarter) stood at $1.6 million in 2021, then crashed by 97.32% to $42000.0 in 2022, then surged by 509.52% to $256000.0 in 2023, then skyrocketed by 64353.12% to $165.0 million in 2024, then plummeted by 97.24% to $4.6 million in 2025.
- Its Receivables - Other was $4.6 million in Q3 2025, compared to $23.4 million in Q2 2025 and $22.8 million in Q1 2025.